查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401862

到 2030 年的神经回馈市场预测：按类型、系统、应用、最终用户和地区进行的全球分析

Neurofeedback Market Forecasts to 2030 - Global Analysis By Type (Electrodes, Amplifiers, Computer Software and Other Products), System, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球神经回馈市场规模将达到 12 亿美元，预计到 2030 年将达到 22 亿美元，预测期内复合年增长率为 9.3%。

神经回馈（NFB），也称为神经疗法，是一种生物回馈，利用操作训练透过提供基于大脑活动的即时回馈来促进健康的大脑功能。 EEG（脑电图仪）通常透过放置在头皮上的感测器记录大脑的电活动，并透过视觉或听觉显示提供回馈。

根据国家医学图书馆 2021 年 4 月发布的资料，思觉失调症每年影响超过 150 万加拿大人。根据世界卫生组织 (WHO) 统计，全球约有 10 亿人患有神经病变，其中约 5,000 万人被诊断出患有癫痫症。

心理健康问题日益增多

神经回馈是针对日益增加的精神疾病而正在研究的治疗方法之一。这种类型的疗法试图透过向患者提供有关脑电波模式的即时回馈来控制大脑活动。精神疾病的增加刺激了对替代疗法的研究，因为与传统治疗方法相比，它们可能具有更高的成功率和更少的副作用。这个因素正在影响市场的扩大。

缺乏报销政策

神经回馈疗法不仅医疗费用高昂，也让医疗专业人员不愿意治疗。缺乏统一的指南和治疗环境可能会导致应用上的差异，并损害神经回馈系统在医疗实践中的声誉和接受度。缺乏足够的补偿可能会阻碍医疗机构投资神经回馈系统，从而限制产业成长。

技术进步

神经回馈在临床环境之外的应用潜力越来越大，包括减轻压力、改善认知功能和提高运动技能。神经回馈的进步使其在临床环境之外广泛应用。借助便携式且易于使用的设备，您可以在家中进行训练并获得专家支援。随着行业技术的不断进步和创新产品的推出，市场正在不断扩大。

神经回馈高成本

高製造和维护成本是由于技术的复杂性，包括感测器、软体和资料处理工具。神经回馈的采用因其高成本而受到阻碍，特别是在医疗资源有限的低度开发国家。这意味着很大一部分人无法使用这些技术，从而限制了市场的扩张。操作这些系统所需的知识和指导也会增加整体成本。

COVID-19 的影响

由于 COVID-19 的爆发，压力、焦虑和心理健康问题不断升级，这可能会导致更多的人寻求神经反馈治疗。然而，对于其他人来说，获得这些治疗方法可能会因不确定性或预算限製而受到阻碍。这场流行病夺走了神经反馈研究和开发计划的资金和注意力。立即管理健康危机成为当务之急。

预计脑血检测领域在预测期内规模最大

脑血检测领域预计将成为预测期内最大的领域。神经回馈中的血脑描记术是一种测量大脑血流波动的方法，特别是额叶皮质的血流波动。它与其他治疗方法（例如医学和认知行为疗法）相结合，以改善治疗结果。神经回馈被认为是治疗多种神经和精神疾病的辅助策略。

预期注意力不足过动症细分市场在预测期内复合年增长率最高

预期注意力不足过动症领域在预测期内复合年增长率最高。注意力不足过动症是儿童最常见的神经发育障碍之一。神经反馈疗法和设备的普及以及对研究和开发的日益关注正在推动这一领域的成长。此外，对研发的日益关注正在创造高效的神经反馈并推动市场成长。

占有率最大的地区

由于拥有设备和套件的先进医疗基础设施，预计北美在预测期内将占据最大的市场占有率。先进的医疗基础设施以及与医院有密切联繫的多家医疗设备公司的存在是该市场成长的关键驱动力。许多公司选择在已开发国家尤其美国进行临床研究，使其成为产业发展的重要组成部分。

复合年增长率最高的地区：

由于政府投资增加了医疗保健基础设施，预计亚太地区在预测期内将保持最高的复合年增长率。它已被应用于治疗疾病，包括焦虑、忧郁症、过动症和其他神经系统问题。在这些国家，健康人群也越来越有兴趣利用神经回馈来改善认知功能。研究机构和科技公司正在研究神经回馈的潜在用途，包括压力管理、运动表现增强和心理健康治疗。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经回馈市场：按产品

  • 介绍
  • 电极
  • 放大器
  • 电脑软体
  • 其他产品

第六章全球神经回馈市场：按系统

  • 介绍
  • 慢皮质电位
  • 频率/功率
  • 低能量
  • 脑血检查
  • 实时 Z 分数
  • 解析度电磁断层扫描
  • 功能性磁振造影
  • 其他系统

第七章全球神经回馈市场：按应用

  • 介绍
  • 焦虑
  • 注意力不足过动症
  • 忧郁症
  • 失眠
  • 吸毒成瘾
  • 思觉失调症
  • 癫痫
  • 疼痛管理
  • 情绪控制
  • 心理健康
  • 其他用途

第八章全球神经回馈市场：依最终用户分类

  • 介绍
  • 医院
  • 神经护理诊所
  • 门诊手术中心
  • 科学研究
  • 培训机构
  • 其他最终用户

第九章全球神经回馈市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Emotiv
  • Brainworks
  • Neuro Care Group
  • Mindfield Biosystems Ltd.
  • Narbis
  • Thought Technology Ltd.
  • Brainmaster Technologies, Inc.
  • InteraXon Inc.
  • Mind Media USA Inc.
  • Mitsar Co. Ltd
  • Wearable Sensing
  • Mind Media BV
  • Stens Corporation
  • Myndlift Ltd
  • NeuralScan
Product Code: SMRC24382

According to Stratistics MRC, the Global Neurofeedback Market is accounted for $1.2 billion in 2023 and is expected to reach $2.2 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Neurofeedback (NFB), also known as neurotherapy, is a kind of biofeedback that uses operant training to encourage healthy brain function by providing real-time feedback based on brain activity. Electroencephalography (EEG) usually records electrical activity from the brain using scalp-mounted sensors and provides feedback through visual or auditory displays.

According to data published in April 2021, on National Library of Medicine, stated that schizophrenia affects more than 1.5 million Canadians every year. According to the World Health Organization (WHO), around 1 billion people globally suffer from neurological disorders, with approximately 50 million people being diagnosed with epilepsy alone.

Market Dynamics:

Driver:

Growing number of mental health issues

Neurofeedback is one of the therapeutic modalities that have been investigated as a result of the rising incidence of mental illnesses. This type of therapy works by giving patients immediate feedback on their brainwave patterns in an effort to control brain activity. Because alternative therapies may be more successful than orthodox treatments and have fewer side effects, research into them has been sparked by the growth in mental health disorders. This element is having an impact on the market's expansion.

Restraint:

Lack of reimbursement policies

Neurofeedback therapy is not only more expensive when it comes to reimbursement, but it also deters medical professionals from providing it. The absence of uniform guidelines and treatment settings may result in differences in application, which might damage neurofeedback systems' reputation and acceptance in the medical field. Insufficient compensation might discourage healthcare institutions from investing in neurofeedback systems, which would limit the growth of the industry.

Opportunity:

Technical advancements

The developments have broadened the range of possible uses for neurofeedback outside of clinical settings, including stress reduction, improving cognitive function, and improving athletic performance. This is now more widely available outside of clinical settings because to advancements. Individuals may receive expert assistance while training at home thanks to equipment that are both portable and easy to use. Due of the industry's ongoing technological breakthroughs and the launch of innovative goods, the market is growing.

Threat:

High cost of neurofeedback

The high cost of production and maintenance can be attributed to the complexity of the technology, which includes the sensors, software, and data processing tools. Adoption of neurofeedback is hampered by its expensive cost, especially in underdeveloped nations with constrained healthcare resources. This means that a large fraction of the population cannot use these technologies, which restricts market expansion. The necessary knowledge and instruction to run these systems also raises the overall cost.

COVID-19 Impact:

Stress, anxiety, and mental health problems have escalated because to the COVID-19 epidemic, which may encourage more people to seek out neurofeedback treatments. For other people, nevertheless, access to these therapies may have been hampered by uncertainty and budgetary limitations. The epidemic took funding and focus away from neurofeedback research and development projects. The urgent health crisis management became the top priority.

The hemoencephalographic segment is expected to be the largest during the forecast period

The hemoencephalographic segment is expected to be the largest during the forecast period. A much more recent method for measuring variations in blood flow in the brain, particularly in the frontal cortex, is hemoencephalography in neurofeedback. To improve treatment results, it is combined with other therapeutic approaches such medicine or cognitive-behavioral therapy. It is regarded as an adjunctive strategy for treating a few neurological and psychiatric disorders.

The attention deficit hyperactivity disorder segment is expected to have the highest CAGR during the forecast period

The attention deficit hyperactivity disorder segment is expected to have the highest CAGR during the forecast period. It is among the most prevalent neurodevelopmental problems in kids. The growing prevalence and the increased attention being paid to neurofeedback therapy and device research and development are what are fueling the segment's growth. Moreover, an increasing focus on research and development is producing efficient neurofeedback, which is promoting market growth.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to advanced healthcare infrastructure with devices and kits. The sophisticated healthcare infrastructure and the presence of several medical device companies with strong ties to hospitals are the main drivers of this market's growth. It is crucial factors in the industry's growth since a lot of corporations choose to do clinical research in developed nations, especially the United States.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising healthcare infrastructure through government investing. It is applied in therapeutic contexts to treat illnesses including anxiety, depression, ADHD, and other neurological issues. In these nations, there is also a rising interest among healthy persons in employing neurofeedback for cognitive advancement. Research organizations and tech firms are investigating its potential uses in stress management, sports performance improvement, and mental health therapy.

Key players in the market:

Some of the key players in Neurofeedback market include Emotiv, Brainworks, Neuro Care Group, Mindfield Biosystems Ltd., Narbis, Thought Technology Ltd., Brainmaster Technologies, Inc., InteraXon Inc., Mind Media USA Inc., Mitsar Co. Ltd, Wearable Sensing, Mind Media B.V, Stens Corporation, Myndlift Ltd and NeuralScan.

Key Developments:

In January 2023, BrainMaster Technologies launched FocusEdu-S, a neurofeedback system for use in schools to improve student learning and behavior. This launch expands BrainMaster's neurofeedback solutions for the education sector.

In September 2022, NeuroCare Group acquired neuroConn, combining two leading German neurofeedback companies. This acquisition strengthens NeuroCare's position in Europe for neurofeedback systems.

In June 2022, Neurofeedback Labs raised $3 million in seed funding to further develop AI-powered neurofeedback training. This investment will support Neurofeedback Labs' growth in digital therapeutics using neurofeedback.

Products Covered:

  • Electrodes
  • Amplifiers
  • Computer Software
  • Other Products

Systems Covered:

  • Slow Cortical Potential
  • Frequency/Power
  • Low-Energy
  • Hemoencephalographic
  • Live Z-Score
  • Low-Resolution Electromagnetic Tomography
  • Functional Magnetic Resonance Imaging
  • Other Systems

Applications Covered:

  • Anxiety
  • Attention Deficit Hyperactivity Disorder
  • Depression
  • Insomnia
  • Drug Addiction
  • Schizophrenia
  • Epilepsy
  • Pain Management
  • Emotional Regulation
  • Mental Fitness
  • Other Applications

End Users Covered:

  • Hospitals
  • Neurocare Clinics
  • Ambulatory Surgical Center
  • Scientific Research
  • Training Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurofeedback Market, By Product

  • 5.1 Introduction
  • 5.2 Electrodes
  • 5.3 Amplifiers
  • 5.4 Computer Software
  • 5.5 Other Products

6 Global Neurofeedback Market, By System

  • 6.1 Introduction
  • 6.2 Slow Cortical Potential
  • 6.3 Frequency/Power
  • 6.4 Low-Energy
  • 6.5 Hemoencephalographic
  • 6.6 Live Z-Score
  • 6.7 Low-Resolution Electromagnetic Tomography
  • 6.8 Functional Magnetic Resonance Imaging
  • 6.9 Other Systems

7 Global Neurofeedback Market, By Application

  • 7.1 Introduction
  • 7.2 Anxiety
  • 7.3 Attention Deficit Hyperactivity Disorder
  • 7.4 Depression
  • 7.5 Insomnia
  • 7.6 Drug Addiction
  • 7.7 Schizophrenia
  • 7.8 Epilepsy
  • 7.9 Pain Management
  • 7.10 Emotional Regulation
  • 7.11 Mental Fitness
  • 7.12 Other Applications

8 Global Neurofeedback Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Neurocare Clinics
  • 8.4 Ambulatory Surgical Center
  • 8.5 Scientific Research
  • 8.6 Training Institutes
  • 8.7 Other End Users

9 Global Neurofeedback Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Emotiv
  • 11.2 Brainworks
  • 11.3 Neuro Care Group
  • 11.4 Mindfield Biosystems Ltd.
  • 11.5 Narbis
  • 11.6 Thought Technology Ltd.
  • 11.7 Brainmaster Technologies, Inc.
  • 11.8 InteraXon Inc.
  • 11.9 Mind Media USA Inc.
  • 11.10 Mitsar Co. Ltd
  • 11.11 Wearable Sensing
  • 11.12 Mind Media B.V
  • 11.13 Stens Corporation
  • 11.14 Myndlift Ltd
  • 11.15 NeuralScan

List of Tables

  • Table 1 Global Neurofeedback Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurofeedback Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurofeedback Market Outlook, By Electrodes (2021-2030) ($MN)
  • Table 4 Global Neurofeedback Market Outlook, By Amplifiers (2021-2030) ($MN)
  • Table 5 Global Neurofeedback Market Outlook, By Computer Software (2021-2030) ($MN)
  • Table 6 Global Neurofeedback Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 7 Global Neurofeedback Market Outlook, By System (2021-2030) ($MN)
  • Table 8 Global Neurofeedback Market Outlook, By Slow Cortical Potential (2021-2030) ($MN)
  • Table 9 Global Neurofeedback Market Outlook, By Frequency/Power (2021-2030) ($MN)
  • Table 10 Global Neurofeedback Market Outlook, By Low-Energy (2021-2030) ($MN)
  • Table 11 Global Neurofeedback Market Outlook, By Hemoencephalographic (2021-2030) ($MN)
  • Table 12 Global Neurofeedback Market Outlook, By Live Z-Score (2021-2030) ($MN)
  • Table 13 Global Neurofeedback Market Outlook, By Low-Resolution Electromagnetic Tomography (2021-2030) ($MN)
  • Table 14 Global Neurofeedback Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 15 Global Neurofeedback Market Outlook, By Other Systems (2021-2030) ($MN)
  • Table 16 Global Neurofeedback Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Neurofeedback Market Outlook, By Anxiety (2021-2030) ($MN)
  • Table 18 Global Neurofeedback Market Outlook, By Attention Deficit Hyperactivity Disorder (2021-2030) ($MN)
  • Table 19 Global Neurofeedback Market Outlook, By Depression (2021-2030) ($MN)
  • Table 20 Global Neurofeedback Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 21 Global Neurofeedback Market Outlook, By Drug Addiction (2021-2030) ($MN)
  • Table 22 Global Neurofeedback Market Outlook, By Schizophrenia (2021-2030) ($MN)
  • Table 23 Global Neurofeedback Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 24 Global Neurofeedback Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 25 Global Neurofeedback Market Outlook, By Emotional Regulation (2021-2030) ($MN)
  • Table 26 Global Neurofeedback Market Outlook, By Mental Fitness (2021-2030) ($MN)
  • Table 27 Global Neurofeedback Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Neurofeedback Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Neurofeedback Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Neurofeedback Market Outlook, By Neurocare Clinics (2021-2030) ($MN)
  • Table 31 Global Neurofeedback Market Outlook, By Ambulatory Surgical Center (2021-2030) ($MN)
  • Table 32 Global Neurofeedback Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 33 Global Neurofeedback Market Outlook, By Training Institutes (2021-2030) ($MN)
  • Table 34 Global Neurofeedback Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.